NATCO Pharma Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹805
- Today's High:
- ₹833
- Open Price:
- ₹810.25
- 52W Low:
- ₹496.7537
- 52W High:
- ₹915
- Prev. Close:
- ₹812.35
- Volume:
- 49164
Company Statistics
- Market Cap.:
- ₹130.76 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
NATCO Pharma Limited had its IPO on under the ticker symbol 524816.
The company operates in the Healthcare sector and Pharmaceuticals industry. NATCO Pharma Limited has a staff strength of 0 employees.
Stock update
Shares of NATCO Pharma Limited opened at ₹810.25 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹805 - ₹833, and closed at ₹822.05.
This is a +1.19% increase from the previous day's closing price.
A total volume of 49,164 shares were traded at the close of the day’s session.
In the last one week, shares of NATCO Pharma Limited have slipped by -8.89%.
NATCO Pharma Limited's Key Ratios
NATCO Pharma Limited has a market cap of ₹130.76 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months NATCO Pharma Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures NATCO Pharma Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, NATCO Pharma Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, NATCO Pharma Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
NATCO Pharma Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NATCO Pharma Limited’s profitability.
NATCO Pharma Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
NATCO Pharma Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹56.57 billion
- Total Liabilities
- ₹6.83 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
NATCO Pharma Limited ended 2024 with ₹56.57 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹56.57 billion while shareholder equity stood at ₹48.74 billion.
NATCO Pharma Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹6.83 billion in other current liabilities, 365000000.00 in common stock, ₹48.37 billion in retained earnings and ₹552.00 million in goodwill. Its cash balance stood at ₹1.32 billion and cash and short-term investments were ₹11.62 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
NATCO Pharma Limited’s total current assets stands at ₹30.00 billion while long-term investments were ₹0 and short-term investments were ₹6.16 billion. Its net receivables were ₹8.56 billion compared to accounts payable of ₹2.64 billion and inventory worth ₹7.43 billion.
In 2024, NATCO Pharma Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, NATCO Pharma Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹822.05
- 52-Week High
- ₹915
- 52-Week Low
- ₹496.7537
- Analyst Target Price
- ₹
NATCO Pharma Limited stock is currently trading at ₹822.05 per share. It touched a 52-week high of ₹915 and a 52-week low of ₹915. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹809.73 and 200-day moving average was ₹630.72 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.